Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.02 USD | -6.05% | -28.11% | -55.60% |
13/06 | Conduit Pharmaceuticals Set to Join Russell 3000 Index Effective July 1 | MT |
14/05 | Conduit Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 7
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Tapolczay
CEO | Chief Executive Officer | 64 | 22/23/22 |
Adam Sragovicz
DFI | Director of Finance/CFO | 55 | 01/21/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Freda Lewis-Hall
CHM | Chairman | 69 | 22/23/22 |
Director/Board Member | 50 | 22/23/22 | |
Faith Charles
BRD | Director/Board Member | 62 | 22/23/22 |
Andrew Regan
BRD | Director/Board Member | 59 | 22/23/22 |
David Tapolczay
CEO | Chief Executive Officer | 64 | 22/23/22 |
Chele Farley
BRD | Director/Board Member | 56 | 22/23/22 |
James Bligh
BRD | Director/Board Member | 36 | 22/23/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 73,829,536 | 9,928,091 ( 13.45 %) | 0 | 13.45 % |
Company contact information
Conduit Pharmaceuticals, Inc.
4995 Murphy Canyon Road Suite 300
92123, San Diego
+
http://www.conduitpharma.comSector
1st Jan change | Capi. | |
---|---|---|
-55.60% | 15Cr | |
+46.03% | 5.57TCr | |
-7.53% | 3.9TCr | |
+35.91% | 3.88TCr | |
-9.38% | 2.73TCr | |
+12.31% | 2.63TCr | |
-16.38% | 2.02TCr | |
+30.79% | 1.28TCr | |
+28.57% | 1.22TCr | |
-0.36% | 1.21TCr |
- Stock Market
- Equities
- CDT Stock
- Company Conduit Pharmaceuticals Inc.